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Validity of the Nurses’ health study physical
activity questionnaire in estimating physical
activity in adults with rheumatoid arthritis
Thomas Quinn1, Michelle Frits BS2, Johan von Heideken3, Christine Iannaccone2, Nancy A. Shadick2,4,
Michael Weinblatt2,4 and Maura D. Iversen2,3,4,5*
Abstract
Background: Patients with rheumatoid arthritis (RA) demonstrate reduced aerobic capacity, excess cardiovascular risk,
mobility limitations and are less physically active than their healthy peers. Physical activity may decrease RA disease
activity through its anti-inflammatory effects and psychological and health benefits. To successfully manage RA symptoms
and reduce cardiovascular risks associated with RA through increased physical activity (PA), accurate physical activity
assessments are critical. Accelerometry is an objective physical activity measure, but not widely used. Validity of the
Nurses’ Health Study physical activity questionnaire II (NHSPAQ) has not been determined for estimation of physical
activity in RA. This study examined NHSPAQ validity in adults with RA compared to accelerometry-based metabolic
equivalents determined (METs) and results of performance tests. We hypothesized NHSPAQ scores would correlate
moderately (0.4–0.5) with accelerometer physical activity estimates.
Methods: Thirty-five adults with RA (mean age [SD] 62 (Williams et. al, Health Qual Life Outcomes 10:28, 2012) years, 28
females (80%) recruited from a hospital-based clinic registry participated in a one-week accelerometry trial. Medical data
was compiled. Participants completed the NHSPAQ, a self-paced 20-m walk test, and modified timed step test.
Participants wore an accelerometer for 7 consecutive days, then completed a physical activity log and another NHSPAQ.
Metabolic equivalents (METs) were derived from NHSPAQ and accelerometers using standardized formulas. NHSPAQ
METs were correlated with accelerometer METs and data from performance measures.
Results: Average disease duration was 21 years (SD = 11), 63% patients took biologics. The average weekly METs
reported were 29 (SD = 33) and accelerometer METs were 33 (SD = 22). NHSPAQ METs correlated moderately with
accelerometer-derived METs (r = 0.48 95% CI (0.15–0.70). Self-reported PA correlated moderately with Step Test
performance (r = 0.50 95% CI (0.18–0.72).
Conclusion: Patients with RA exhibit low physical activity levels. General fitness measures were moderately correlated
with physical activity levels. A moderate significant correlation existed between NHSPAQ and accelerometry METs.
These preliminary data suggest the NHSPAQ may be useful to describe physical activity levels in this population.
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Background
Rheumatoid arthritis (RA) associated symptoms such as
joint damage, joint pain, inflammation, and cardiovascu-
lar disease place these adults at greater risk of physical
inactivity [1]. Even among those with well-controlled
disease, adults with RA are less physically active than
people who are disease-free [2, 3]. To successfully man-
age RA symptoms and reduce cardiovascular risks
associated with RA through increased physical activity
(PA) [4], an accurate measure of daily activity is essential
for both the clinician and the patient.
Accelerometers, devices that measure bouts of PA
above resting metabolic rate [5] are used in epidemio-
logic studies to ascertain estimates of PA [6]. From these
measurements, metabolic equivalents of energy expend-
iture (METs) of tasks can be derived based on the
duration and type of activity [7]. Maximal exercise test-
ing enables the ascertainment of METs but requires
expensive equipment and skilled clinicians whereas
accelerometry provides an indirect estimate of METs
and does not require large equipment (oxygen uptake
equipment) nor skilled clinicians. One MET is oper-
ationally defined as the quantity of oxygen consumed
while sitting at rest and equals 3.5 milliliters of oxygen
per kilogram of body weight per minute. This MET no-
tion represents a practical and understandable method
for expressing the energy cost of physical activities in
relation to resting metabolic rate [7]. Unfortunately,
widespread clinical use of the maximal exercise testing
to derive METs is not practical due to time constraints
and costs. A simpler, more cost-effective method to
accurately determine daily PA including estimated METs
in adults with RA is clinically necessary to effectively
manage RA symptoms through exercise and increased
daily activity.
Physical activity is commonly defined, “as any bodily
movement produced by skeletal muscles that requires
energy expenditure” [8]. Physical activity questionnaires
(PAQ) are often used in settings where more objective
PA measurements are not practical or possible [9, 10].
Typically, PAQs gather information about leisure activ-
ity, exercise duration and intensity, and other measures
of daily activity. Numerous PAQs exist and have been
validated for use in specific cohorts where estimation of
PA is particularly relevant [9, 11–13]. The International
Physical Activity Questionnaire [11], Behavioral Risk
Factor Surveillance System [12], Physical Activity Recall
[13] and the Nurses’ Health Study Physical Activity
Questionnaire II (NHSPAQ) [14, 15] are designed to de-
scribe PA behaviors, whereas the Neighborhood Envir-
onment Walkability Scale [16] is designed to describe
aspects of the environment that promote PA or create
barriers to PA. Each of these instruments has strengths
and weaknesses. However, for a specific questionnaire to
be used for a given population, it must first be validated
in the target population. Initial validation studies of
PAQs, such as the NHSPAQ, compared subject re-
sponses to items on the survey with PA diaries and logs
[14]. The most accurate way to determine the validity of
self-reported physical activity is through direct compari-
son with an objective measure.
The NHSPAQ is a self-reported PAQ originally devel-
oped for the Nurses’ Health Study [14, 15]. The ques-
tionnaire contains a series of items regarding PA such as
modes of exercise, walking pace, flights of stairs climbed
as well as items ascertaining sedentary activities (e.g. sit-
ting). Responses include options related to the duration
of activity for each mode, number of flights climbed and
time spent sitting. The NHSPAQ was developed to re-
port PA modes as well as derived METs. The calculation
to derive METs uses the frequency, duration, and mode
of PA (e.g. strength training), assuming moderate inten-
sity for each activity and estimates of METs from the
American College of Sports Medicine [17], summed
across all modes reported [14].
We chose the NHSPAQ because it is a brief PAQ that
has been validated for use in numerous large epidemio-
logic cohort studies of patients with chronic health condi-
tions to ascertain METs of PA and examine the
relationship between PA and disease outcomes [17–19].
However, the NHSPAQ has not been validated for use in
patients with RA. Given the ever-increasing role of PA in
the management of RA and to follow PA trends in large
epidemiologic studies in these patients, it is pertinent to
consider the NHSPAQ for clinical use in RA. While the
gold standard comparison for assessing METs is indirect
calirometry, we aimed to examine the concurrent validity
of the NHSPAQ-derived METs and accelerometer-derived
METs for determining PA levels in adults with RA. We
hypothesized that NHSPAQ-derived METs would correl-
ate moderately and positively with METs measured using
accelerometers (r = 0.4 to 0.5). We further hypothesized
that performance on the aerobic test would have a low to
moderate correlation with self-reported PA levels (r = 0.3
to 0.5) given these are assessed at a single point in time,
versus report of weekly PA.
Methods
Institutional Human Subjects approval was obtained for
this secondary study and all subjects consented to
participate.
Design and recruitment
This seven-day validation study took place from March,
2011 through September, 2012. Subjects were recruited
through a clinical registry located in a large tertiary
medical center. The RA registry [20] is a comprehensive
database of over 1,000 patients with RA [21]. Patients in
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the registry met the following criteria: age 18 years or
greater, doctor diagnosed RA or met the American Col-
lege of Rheumatology criteria for RA [22] and agreed to
participate. A statistician used a computer program to
randomly select individuals from the registry who re-
ported PA levels in the top decile and bottom decile of
METs based on their responses to the NHSPAQ items.
We selected subjects who were in the extreme ends of
the PA spectrum in this sample to determine whether
the questionnaire is useful and valid for individuals who
are sedentary and highly active. An invitation letter was
then mailed to these individuals explaining the study
purpose and requesting participation. The research as-
sistant contacted interested subjects by phone to screen
subjects for eligibility. Eligibility included: no current en-
gagement in swimming or other water-based exercise
and medical history precluding participation (uncon-
trolled heart disease). Appointments were scheduled to
coincide with an upcoming rheumatology appointment
at the hospital’s rheumatology clinic.
Protocol and measures
Demographic data, RA disease activity (biomarkers and
physical examination data) and health status information
(mood state and disability) were obtained from the RA
registry for the most recent annual visit. During the visit,
patients provided a blood sample for an array of clinical
measures including: C-reactive protein (CRP), rheuma-
toid factor (RF), and anti-cyclic citrullinated peptide
(anti-CCP) antibodies. Demographic data included sex,
age, education, race, marital status, employment, and
medications were obtained from the registry. RA disease
activity was assessed using the Disease-Activity Score
with C-Reactive Protein (DAS-CRP3) [23, 24]. The
DAS-CRP3 combines a biomarker of disease activity −
C-reactive protein −with an overall measure of disease
activity including swollen and tender joints, as assessed
by the rheumatologist and the patient’s global assess-
ment of disease activity [23, 24]. DAS-CRP3 scores were
obtained during the patient’s annual rheumatology visit
and range from 0 to 10. Scores were classified as: low ac-
tive (<3.2), moderately active (3.2–5.1) and highly active
(>5.1). To ensure the most precise correlation of disease
activity and physical activity possible, DAS-CRP3 values
were taken from the annual visit closest to the patient
intake date, an average of 4 months.
Mood state was assessed using the Mental Health Status
Index (MHI-5) [25], a 5-item scale that assesses mental
health status with scores range from 0 to 100, where
higher scores indicate better mental health. This instru-
ment has been validated and recommended as a tool to
screen for mood disorders [26]. RA-related disability was
assessed with the Multidimensional Health Assessment
Questionnaire (MDHAQ), a valid and reliable measure of
disability and function [27, 28] in adults with RA with
scores ranging from 0 to 3 (worse function). The
MDHAQ is a self-report questionnaire designed specific-
ally for patients with RA and includes items regarding ac-
tivities of daily living, pain, psychological status and global
health status. All of the patient reported outcome mea-
sures are routinely used in studies of adults with RA.
At intake, participants completed an initial NHSPAQ
[14] and performance tests conducted in random order,
under the supervision of an experienced physical therap-
ist who was blinded to subjects' PA status. The
NHSPAQ contains items regarding the time and energy
spent during the previous week performing various tasks
such as climbing stairs, walking, running, and various
forms of exercise. Additionally, the questionnaire gathers
information about average gait speed and the amount of
time spent in sedentary activities. The data are combined
in a standardized algorithm to determine the METs
expended during the previous week.
The Timed 20-meter Walk Test [29] was administered
to provide information about average gait speed. This
self-paced walk test is both valid and reliable in measur-
ing average gait speed and functional performance in
adults with arthritis [29]. A 20-meter course was mea-
sured and marked clearly at the starting and ending
points. Patients were instructed to complete the course
at their normal walking pace, making sure to continue
through the end point without reducing their speed. To
minimize outside influences on gait speed, the investiga-
tor remained stationary at the end of the course while
timing each participant. The time taken to complete the
course was recorded along with the number of steps
taken. Each subject completed three trials of the course,
and the average values were used in analysis.
Participants also completed a modified step test [30, 31]
as a measure of resting, active, and recovery heart rates,
and overall physical fitness. The step test provides valid
and reliable estimates of aerobic capacity and respiratory
exchange rate and consisted of three bouts of 3-min inter-
vals on an 18 cm step while heart rate was monitored
using a pulse oximeter. Heart rate was assessed at base-
line, 5 s after completion of bout, and one minute after
completion. Patients rested for one minute between each
bout of exercise. Metabolic rate was determined from
metabolic equivalents (METs) provided by data from the
American College of Sports Medicine (ACSM) [32] for
various stepping rates at specified step heights [31].
Upon completion of the two performance measures,
participants were given an Actigraph© tri-axial acceler-
ometer. Gyroscopic accelerometers quantitatively meas-
ure daily activity by recording peaks in acceleration in
all three planes of movement (frontal, sagittal and trans-
verse) over time. Studies have established the validity
and reliability of accelerometers in many populations
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including adults with RA [33, 34]. From these measure-
ments, METs can be calculated using subject weight and
activity duration. Prior to administration, the device was
synchronized with the subject’s height, weight, and date
of birth. Participants were instructed to wear the device,
centered over the hip on their dominant side. The inves-
tigator placed the device on the patient to ensure appro-
priate positioning of the accelerometer. Patients were
also told not to participate in any water sport activities
during the study as the device cannot be worn in the
water. They were also instructed to remove the device
while bathing, and could remove it before going to bed
at night. Participants received written and oral instruc-
tions reviewing the protocols along with a daily activity
log to record general patterns of activity throughout the
day. Participants recorded the time the device was worn
and removed each day, as well as any periods of rest that
could be misinterpreted as periods of non-wear. Subjects
wore the accelerometer for seven days. At the comple-
tion of the 7th day, the device automatically stopped
recording. Patients were instructed to complete a second
NHSPAQ form at the end of the week and return the
device, exercise log and NHSPAQ via mail using a pre-
paid mailing carton (delivery information included).
Analysis
All data was doubled entered and verified for accuracy
by a third person. SAS Software, version (9.2) of the SAS
System for [PC] © SAS Institute, was used to analyze
demographic data and determine the correlation be-
tween the various performance measures and PA data.
Standard METs for each activity reported via the
NHSPAQ were calculated using the average duration,
frequency, and intensity of the activity over the week. In-
dividual METs from each activity were then summed
and the total METs for the week were calculated. From
the total weekly METs, average daily METs can be
quickly and easily determined. METs for the timed-step
test were calculated using values provided by the ACSM
guidelines for an 18-cm step with step rates of 20–30
steps per minute. To calculate METs when stepping
rates were outside this range, a linear regression was
used to determine METs for all stepping rates. Stepping
rate was plotted against the associated METs provided
by the ACSM [32], and a formula relating the two vari-
ables was generated with R2-value 0.997.
Data from the accelerometry trials were analyzed using
Actigraph software ©, which calculates total weekly METs
by relating the duration and intensity of daily activities to
the weight of the subject using a standardized formula.
METs are reported in terms of the rate of oxygen con-
sumption (in liters per minute) per kilogram of body
weight, per minute of exercise. Correlations and corre-
sponding 95% Confidence Intervals (CI) were used to
determine associations with METs derived from accelero-
metry, performances tests and the NHSPAQ. Although
subjects were asked not to engage in swimming during
this study, five individuals reported swimming during the
study period and removed the accelerometer when they
swam. As a result, we examined total NHSPAQ METs
with and without the METs associated with swimming in
the total weekly METs calculation. A Bland-Altman plot
[35] was used to analyze the agreement between NHSPAQ
METs and those derived from the accelerometer. A
Wilcoxon Ranked Sum Test examined whether
accelerometer-derived METs differed between those indi-
viduals reporting high and low levels of PA engagement.
Gpower software [36] was used to calculate power. With
an alpha set at 0.05 and a correlation of 0.60, the study
sample of 35 was sufficiently powered at 90%.
Results
Subjects
One hundred and nine subjects were identified by the
statistician and mailed information about the study.
Sixty-one patients expressed interest in learning more
about the study and gave permission to be called.
Thirty-five patients consented to participate (Fig. 1). Of
these 35, 34 (97%) were Caucasian, 28 (80%) were
Potentially
Eligible
n=109
Not Interested 
Do NOT 
Contact
n=25
Unable to 
Contact
n=23
Interested and requested 
phone call OR called after no 
response to invitation
n=61
Ineligible
n=5
Non-responsive
n=19
Accepted and 
Scheduled
n=37
Consented
n=35
No shows
n=2
Fig. 1 Recruitment Results for Accelerometry Trial in Rheumatoid Arthritis
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female, the mean age was 62 years (SD = 10), all were well
educated (60% graduated college or had attended graduate
school and had graduate degree) and most had longstand-
ing RA. Patients exhibited moderate disease activity and
good mental health status. For details see Table 1.
Subjects averaged a metabolic rate of nearly 5 METs
during the self-paced, modified step test. There was a
low but significant correlation between performance on
the modified step test and gait speed [Timed Walk (r= 0.39;
95% CI 0.05–0.64)]. Average baseline NHSPAQ-derived
METs per week were 29 (SD = 33) and average NHSPAQ-
derived METs on follow up were 25 (SD= 27) including
those who reported swimming and 21 METS (SD= 21),
excluding those who reported swimming. Average
accelerometer-derived weekly METs measured slightly
higher, at 33 METs (SD = 22). Most individuals reported
walking or climbing stairs during the week as their primary
modes of physical activity (Table 2).
Baseline NHSPAQ-derived METs correlated moderately
and significantly with the Modified Step Test (r =0.50;
95% CI = (0.18–0.72) but not with average gait speed (r =
0.06; 95% CI = −0.29–0.39). With respect to RA disease
status, there was a moderate negative correlation between
disease activity and NHSPAQ METs (r = 0.48; p = 0.007).
Disability, as measured by the MDHAQ, did not correlate
with either the NHSPAQ METS or the accelerometer-
derived METS (Table 3).
A visual display of the relationship between METs-
derived from the NHSPAQ and the accelerometer-derived
METs in a scatterplot illustrates one outlier who reported
more than 11 h of swimming during the week. This was
confirmed by examining the patient’s weekly PA logs. As
this accelerometer cannot be worn in water, excluding the
subject from the analysis resulted in a stronger correlation
between the NHSPAQ METs and the accelerometer METs
(r = 0.7; 95% CI = 0.49–0.85). Thus, we plotted the
relationship between NHSPAQ-derived METs and
accelerometer-derived METs with this person removed and
found a moderate and significant correlation between these
two variables (r = 0.48; 95% CI = (0.15–0.70)) (Fig. 2).
Table 1 Demographic and clinical characteristics of adults with
rheumatoid arthritis participating in the accelerometry trial (n= 35)
Variable Number
(%)
Mean
(SD)
Median
(IQR)
Female 28 (80)
Caucasian 34 (97)
Age (y) 62 (10) 62 (52–68)
Married 30 (86)
Employed 13 (37)
Graduated high school/
attended college
14 (40)
Graduated college/
attended graduate school
21 (60)
Disease Duration (y) 21 (11) 19 (11–32)
Medications
Biological DMARDs 22 (63)
Methotrexate 18 (51)
TNF inhibitor 18 (51)
NSAIDs 12 (34)
Steroids 14 (40)
Disease markers
Rheumatoid factor >15 21 (60)
Anti-CCP positive 24 (69)
Seropositive 25 (71)
DAS-CRP3a 3.2 (1.5) 2.9 (1.9–4.3)
Disease activity (RADAI) 2.9 (2.1) 2.3 (1.2–4.7)
Self-reported outcomes (PROs)
Multi-dimensional health
Assessment
Questionnaire (MDHAQ)
0.62 (0.54) 0.55 (0.1–1.0)
Quality of life (Euroqol Index) 0.8 (0.2) 0.8 (0.7–0.8)
Mental health score (MHI-5)b 79 (17.4) 83 (73–90)
Performance Measures
20 m Timed walk (s)
Number of steps 28 (4.5) 26 (24.3–30.7)
Time taken (seconds) 16.1 (3.8) 15.7 (12.9–17.4)
Timed Step test (METs)a 4.7 (0.8) 4.8 (4.3–5.1)
aFrequency Missing = 1
bFrequency Missing = 4
SD Standard deviation
IQR Interquartile range
Table 2 Average metabolic equivalents derived from NHSPAQ
at baseline intake, and from accelerometers along with
participation rates in specific physical activities among adults
with RA (n = 35)
Measure Calculated METs
Mean (SD)
Median
(IQR)
NHSPAQ II (Baseline) 29 (33) 21 (8–35)
NHSPAQ II (Week 1) 25 (27) 20 (6–30)
ActiGraph accelerometer (week 1) 33 (22) 28 (18–39)
Participation in various physical
activity modes
Number (%)
Walk 33 (94.3)
Jog 5 (14.3)
Run 1 (2.9)
Swim 5 (14.3)
Bicycle 12 (34.3)
Calisthenics 10 (28.6)
Tennis 1 (2.9)
Stair climbing 32 (91.4)
SD Standard deviation
IQR, Interquartile range
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A Bland-Altman Plot was used to further examine the
relationship between accelerometer-derived METs and
NHSPAQ-derived METs. The plot indicates limits of
agreement between the different two measures of PA,
providing upper and lower limits that are +/− 1.96
standard deviations of the average difference between
METs calculations. The magnitude of the agreement of
these two measures is clinically insignificant, suggesting
these two measures may be used interchangeably. (Fig. 3).
To further validate patient self-report of PA using the
NHSPAQ, we examined accelerometer-derived METs
between participants who self-reported high levels of PA
and those self-reported low levels of PA, defined as be-
ing in the top and bottom decile of NHSPAQ METs.
Data indicated that median accelerometer METs differed
significantly between the two groups (median high = 39;
median low = 24; z = 0.01; p = 0.007).
Discussion
Given the evidence suggesting individuals with RA are at
high risk for cardiovascular disease, this study aimed to
examine the validity of the NHSPAQ in the estimation
of daily PA levels in adults with RA, in order to deter-
mine whether the NHSPAQ might be useful in clinical
practice or in large epidemiologic studies of PA in RA.
Our data demonstrated a significant moderate correlation
between NHSPAQ-derived METs and accelerometer-
derived METs. While the correlation is modest, it is higher
than correlations found between the NHSPAQ and PA
diaries [14] and slightly higher than comparisons with
other PA scales when used in adults with RA [37]. In a re-
cent study of 50 adults with RA [38], the relationship
between accelerometry and scores derived from the Inter-
national Physical Activity Questionnaire (IPAQ) data was
low to moderate [quadratic weighed kappa index 0.27
(0.06–0.48), p = 0.02]. Thus, our data suggest the
NHSPAQ shows promise as a tool for determining PA
levels in adults with RA. The Bland-Altman plot provides
further confirmation that the NHSPAQ may provide a
reasonable estimate of PA levels. However, the Bland Alt-
man plot also suggests that among adults with RA who
are sedentary, the relationship between NHSPAQ and ac-
celerometer may be less reliable. Further, research is war-
ranted to determine the effects of extreme activity levels
(high or low) on the accuracy of the questionnaire.
In this study of patients with well established RA, PA
levels were low. However, these PA levels are similar to
data reported in other studies of PA in adults with RA
[37–40]. In addition, we found a non-significant correl-
ation between PA and physical function. While this
Table 3 Correlations between metabolic equivalents (METs)
derived from performance tests on day of intake, self-reported
disability and from accelerometers among adults with RA (n= 35)
Variables Correlation
Strength
95% Confidence
Limits
NHSPAQ METs
With accelerometer METs 0.48 0.15–0.70
With modified step-test METs 0.50 0.18–0.72
With disability (MDHAQ) −0.24 −0.54–0.12
Actigraph accelerometer METs
With modified step-test METs 0.39 0.05–0.64
With walk-test speed −0.50 −0.71–-0.19
With disability (MDHAQ) −0.21 −0.51–0.15
N
H
S
P
A
Q
 M
E
T
s
0
20
40
60
80
100
120
Accelerometry METs
0 20 40 60 80 100 120
r = 0.48 
p = .006
N
H
S
P
A
Q
 M
E
T
s
0
20
40
60
80
100
120
Accelerometry METs
0 20 40 60 80 100 120
r = 0.7; p =.0001
a b
Fig. 2 Correlation between metabolic equivalents (METs) derived from the NHSPAQ and from the accelerometer in adults with Rheumatoid Arthritis.
a Scatterplot of Accelerometer METs with NHSPAQ Mets with Outlier included. b Scatterplot of Accelerometer METs with NHSPAQ Mets with
Outlier excluded
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result may be surprising, Conigliano et al. [38] also re-
ported PA was not associated with function, as measured
by the HAQ. It is difficult to draw any conclusion about
the relationship of disease activity to PA as disease
activity, measured by the DAS-CRP3, was assessed at
annual visits, and in some cases this was an average of
4 months from the accelerometry trial intake.
There were low correlations between physical per-
formance measures of aerobic status and gait speed with
self-reported PA levels (NHSPAQ). Specifically, a moder-
ate positive correlation was noted between NHSPAQ
METs and performance on the modified step-test (r = 0.50;
p = 0.003), indicating that individuals who are more physic-
ally active tended to perform at a higher level during this
test. This finding is interesting clinically because the data
suggest that the NHSPAQ, although used as an estimation
of PA over one-week, might also be useful as an indicator
of general fitness.
Overall, METs obtained from both the NHSPAQ and the
accelerometers illustrate that persons with RA engage in far
less PA than is recommended for the average person in the
general population. The amount of time engaged in moder-
ate to vigorous activity is shown to decrease dramatically
across the population after the age of 16 [4], so it is to be
expected that older persons would present as less physically
active than their younger counterparts. However, when
adjusting for age, patients with RA still vastly underperform
in terms of their daily PA levels. The 2008 Physical Activity
Guidelines for Americans recommends adults perform 500
to 1,000 METs of activity per week, which corresponds to
at least 150 min of moderate exercise or 90 min of vigorous
physical activity per week [41]. Updated guidelines for older
adults recommends 150 min of moderate or 75 min of vig-
orous physical activity per week [42]. Inactivity is defined as
less than 40 METs per week. According to these guidelines,
the majority of participants in this study would be consid-
ered sedentary. This finding is supported by a 2012 study
by Dr. Lee et al. [40], investigating PA in 176 adults with
RA, 40% of the patients with RA were considered physically
inactive by today’s guidelines with only 12% meeting even
the minimum weekly exercise recommendations. In light of
these and other similar findings, it is not surprising that the
overall activity levels for patients with RA in this study were
significantly lower than those indicated by ACSM. Clearly,
although the benefits of exercise are well known, there are
major obstacles that need to be overcome in order to
increase PA levels in individuals with RA.
Strengths/limitations
A major strength of this study is the use of the RA
Registry that allowed us to ascertain biomarkers of dis-
ease activity without the need of additional time or re-
sources and facilitated subject recruitment. We sampled
patients based on prior self-report of PA to gather sub-
jects at extreme end of PA levels and the investigator
was blinded to PA levels at intake. Additionally, we com-
pared a self-report PA questionnaire which includes ac-
tivities that involve primary joints affected by RA and
compared the data to simple clinical performance mea-
sures and an accelerometer. Each of these calculations
rely on METs derived from standard formulas using
ACSM criteria and do not require extensive equipment
and costs associated with more comprehensive clinical
tests. Limitations of the study include the small study
sample. However, power calculations suggest we were
sufficiently powered. Another limitation is the relative
homogeneity of subjects with respect to race, socio-
economic status, and high educational attainment. This
Fig. 3 Bland-Altman plot illustrating relationship between NHSPAQ derived metabolic equivalents (METs) and METs derived from the accelerometer
among adults with RA (n = 34). The figure on the left shows the Bland-Altman plot without the outlier and the one on the right with the outlier
(NOTE: scale changes with deletion of outlier). The Bland-Altman plot indicates where the greatest variance in METs calculation occurs between the
NHSPAQ and accelerometer trials. Upper and lower limits are +/- 1.96 standard deviations of the average difference between METs calculations
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may limit generalizability, as these patients may be more
likely to accurately report PA and be more adherent with
the accelerometer. Additionally, we recognize that corre-
lations have numerous assumptions that may influence
the interpretation of data. Finally, the DAS-CRP3 meas-
ure of disease activity may not be a complete reflection
of current disease state at the time of the accelerometry
trial and may have attenuated the reported correlations
due to the time difference between sampling of bio-
markers (conducted at annual registry visit) and acceler-
ometer intake (an average of 4 months).
In this sample, adults with RA did not meet the ACSM
requirements for PA despite relatively well-controlled
RA disease. The relative ease of completing the
NHSPAQ and short survey length, along with modest
correlations with accelerometry data, suggests the
NHSPAQ could potentially be useful in large epidemio-
logical studies of PA in RA, though further study with
larger samples is needed.
Conclusions
Patients with RA exhibit low physical activity levels.
General fitness performance measures were moderately
correlated with self-reported physical activity levels and
with accelerometer data. A moderate significant correl-
ation existed between NHSPAQ derived METs and
accelerometry METs. These preliminary data suggest the
NHSPAQ may be useful to describe physical activity
levels in this group of patients.
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